Gut & gigabytes - Global Data & Analytics Survey
Big decisions in the pharma and life sciences industries
The global balance of economic power has been shifting from developed to developing countries. As this trend continues, it will have an increasing impact on where growth opportunities arise for companies – and on where they invest to capitalise on those opportunities. Learn more.
Pharma 2020: From vision to decision
In this report, we focus on how companies can reach 2020 in a position to benefit from more favourable conditions thereafter.
The pharmaceutical industry is at a critical juncture. The tools to develop remarkable new medicines are materialising, demand for its products is increasing and the barriers to free trade are falling. Learn more.